By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Scintilla Pharmaceuticals 



San Diego  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Scintilla Pharmaceuticals, is a subsidiary of Sorrento Therapeutics. Scintilla's lead program is RTX for the treatment of opiate refractory cancer pain. The RTX program has been tested successfully in a Phase 1 - 2 clinical trial, and is scheduled to commence Phase 2 clinical trials in early 2017.



Key Statistics


Email:
Ownership: Private

Web Site: Scintilla Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->